Nutravigilance: principles and practices to enhance adverse event reporting in the dietary supplement and natural products industry
- PMID: 24112316
- DOI: 10.3109/09637486.2013.836743
Nutravigilance: principles and practices to enhance adverse event reporting in the dietary supplement and natural products industry
Abstract
Nutravigilance is defined as "the science and activities relating to the detection, assessment, understanding and prevention of adverse effects related to the use of a food, dietary supplement, or medical food". The nutravigilance approach is derived from well-defined principles of pharmacovigilance in the drug and biologics industries, which have been developed and refined over a number of years through expert recommendations. While the primary purpose of nutravigilance is to protect customer/patient safety, it also serves to reduce product liability risks for manufacturers and marketing agents of such products. Compliance with the current FDA adverse event reporting requirements is suboptimal, and FDA oversight and enforcement activities have recently increased. In order to better protect customer and product safety, dietary supplement manufacturers must significantly change their current approach, and demonstrate a proactive, systematic, risk-based, scientific approach to product safety, similar to one utilized successfully in the pharmaceutical industry. While this article focuses on FDA regulations, the principles are widely relevant to the supplement industry in the rest of the world.
Similar articles
-
Dietary supplement adverse event reports: review and analysis.Food Drug Law J. 2009;64(3):503-13. Food Drug Law J. 2009. PMID: 19999641
-
Serious Adverse Events Reported with Dietary Supplement Use in the United States: A 2.5 Year Experience.J Diet Suppl. 2020;17(2):227-248. doi: 10.1080/19390211.2018.1513109. Epub 2018 Dec 4. J Diet Suppl. 2020. PMID: 30513022
-
FDA regulation of dietary supplements and requirements regarding adverse event reporting.Clin Pharmacol Ther. 2010 Feb;87(2):239-44. doi: 10.1038/clpt.2009.263. Epub 2009 Dec 23. Clin Pharmacol Ther. 2010. PMID: 20032973
-
The state of dietary supplement adverse event reporting in the United States.Pharmacoepidemiol Drug Saf. 2008 Oct;17(10):962-70. doi: 10.1002/pds.1627. Pharmacoepidemiol Drug Saf. 2008. PMID: 18613260 Review.
-
Ephedra: yesterday, DSHEA, and tomorrow--a ten year perspective on the Dietary Supplement Health and Education Act of 1994.J Herb Pharmacother. 2005;5(3):67-86. J Herb Pharmacother. 2005. PMID: 16520299 Review.
Cited by
-
Nutrivigilance: the road less traveled.Front Pharmacol. 2023 Oct 11;14:1274810. doi: 10.3389/fphar.2023.1274810. eCollection 2023. Front Pharmacol. 2023. PMID: 37886131 Free PMC article. No abstract available.
-
Post-Menopausal Vaginal Hemorrhage Related to the Use of a Hop-Containing Phytotherapeutic Product.Drug Saf Case Rep. 2015 Dec;2(1):14. doi: 10.1007/s40800-015-0016-2. Drug Saf Case Rep. 2015. PMID: 27747726 Free PMC article.
-
Online Availability of Diamond Shruumz Before and After FDA Recall Initiation: Qualitative Assessment and Simulated Test Purchasing.J Med Internet Res. 2025 Jun 30;27:e64820. doi: 10.2196/64820. J Med Internet Res. 2025. PMID: 40586741 Free PMC article.
-
Nutrivigilance - The need of the hour.Indian J Pharmacol. 2023 Jan-Feb;55(1):62-63. doi: 10.4103/ijp.ijp_772_22. Indian J Pharmacol. 2023. PMID: 36960523 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical